Charles River Laboratories International, Inc. closed at $357.35 on October 27, 2026, rising 3.51% in the latest 24-hour session. The move extended a notable stretch of momentum for the stock.
Over the past seven days, CRL has climbed 19.12%, with the broader 30-day window showing an even larger advance of 21.90%. The sustained gains have pushed the company's market capitalization to $16.49 billion.
The back-to-back sessions of appreciation reflect a period of consistent buying activity in CRL shares. The stock's performance over the past month stands among the more pronounced moves in its recent trading history based on the available figures.
As of the October 27, 2026 close, Charles River Laboratories remains one of the more active names in its sector, with traders and market observers tracking whether the current momentum will be sustained in subsequent sessions.
